The Impact of The Apfel Scoring System For Prophylaxis of
The Impact of The Apfel Scoring System For Prophylaxis of
The Impact of The Apfel Scoring System For Prophylaxis of
Abstract
Background and Aims: Post‑operative nausea and vomiting (PONV) is common, undesirable, and stressful following surgery.
By focusing attention and resources on those groups of patients most likely to develop PONV, the quality of care provided to
the patients can be improved. The primary objective was to compare the incidence of PONV after implementation of the Apfel
scoring system with the control group receiving prophylaxis for every surgery. The secondary objective was to identify the effect
on the patient’s expenditure/savings with respect to management of PONV.
Material and Methods: This prospective randomized controlled double‑blinded study enrolled 70 patients undergoing
surgeries under general anesthesia. Patients were randomized to group A (control group – all received PONV prophylaxis) and
group B (Apfel stratification performed for PONV prophylaxis). Based on the Apfel system, the risk of PONV was classified as
the grades low, moderate, and high risk. Patients at moderate and high risk received PONV prophylaxis in group B. Patients
were monitored for PONV during 24 h after surgery and rescue medication given as required. The effect of implementing Apfel
risk stratification on the incidence of PONV (primary outcome measure) and on patient expenditure was compared.
Results: Compared to administering prophylaxis for all patients, the incidence of PONV [group A‑5 patients (14.3%)] did
not increase (P = 0.428) after implementing the Apfel scoring system [group B‑2 patients (5.7%)]. The number of patients
spending on prophylaxis for PONV in group A [35 (100%)] was higher than that in group B [17 (48%)], without increasing
expenditure on PONV treatment.
Conclusion: Withholding prophylaxis on the basis of the Apfel scoring system did not increase the incidence of PONV
compared to providing prophylaxis for all the patients. The overall cost of prevention and treatment of PONV is less when the
Apfel scoring system is used.
Keywords: Apfels` scoring system, post‑operative nausea and vomiting, prophylaxis for PONV
© 2023 Journal of Anaesthesiology Clinical Pharmacology | Published by Wolters Kluwer - Medknow 463
Avinash and Krishna: Impact of Apfel scoring system on PONV
care. The practice of PONV prophylaxis for every patient On the day of surgery, adequate fasting was confirmed and
undergoing surgery under general anesthesia is seen in many patients were shifted into the operating room. Consenting
institutions.[4] This practice has been questioned because adults were randomly allotted to receive routine PONV
not all patients undergoing surgery under general anesthesia prophylaxis (group A) or PONV prophylaxis (group B) as
develop PONV.[5] Scoring systems to predict PONV and per the risk by opening the sealed envelope containing the group
identify patients at increased risk for PONV are described allocation for the patient based on the computer‑generated
in the literature.[4] Such scoring systems or risk stratification random number table. In GROUP A, PONV prophylaxis
systems as introduced by CC Apfel et al.[6,7] (Germany) and was provided to all patients with intravenous (IV) ondansetron
Koivuranta M et al.[8] (Finland) are used to provide PONV 0.1 mg/Kg, rounded off to the nearest unit decimal,
prophylaxis to only those patients at high risk for PONV.[4] administered about 30 min prior to expected completion of the
surgery. In GROUP B, PONV prophylaxis was provided
This study evaluates the effect of applying risk stratification to the patients with IV ondansetron 0.1 mg/Kg, rounded off
of the Apfel scoring system on the incidence of PONV and to nearest unit decimal, administered about 30 min prior to
its impact on patient expenditure/savings. expected completion of the surgery on the basis of the Apfel
score [i.e., only the moderate (score 2) and high (score 3,
The primary objective was to compare the incidence of 4) risk patients received prophylaxis, whereas the low risk
PONV after implementation of the Apfel scoring system with patients (score 0, 1) did not receive prophylaxis]. The group
the control group receiving prophylaxis for every surgery. The allocated was not revealed to the patient, and the specially
secondary objective was to identify the impact of the scoring instructed nurse or anesthesiology resident assessed the number
system on the patient’s expenditure/savings with respect to of episodes of nausea and vomiting in the post‑anesthetic care
management of PONV. unit for 24 h after surgery, thus ensuring blinding.
neuro‑muscular blockade was performed using a combination mass index) were compared with the Student t‑test. Gender
of IV neostigmine and glycopyrrolate based on the weight distribution and distribution of Apfel scores in both the groups
of the patient and extubation was performed. PONV was were compared with the Chi‑square test. The incidence of
monitored for 24 h as episodes complained by the patient or PONV was compared with the Fisher exact test. A P value
observed by the nurse. The rescue antiemetic that was used less than 0.05 was considered significant.
in the case of PONV was IV metoclopramide 10 mg. If the
PONV episodes persisted despite this rescue medication, Result
then IV dexamethasone 0.2 mg/kg was administered. The
requirement for rescue medications was recorded. There were Figure 1 shows the consort flow chart of the study. Patient
two observers in the study. Observer 1 was the anesthesiology characteristics are given in Table 1. Table 2 shows the Apfel
resident who performed the pre‑operative evaluation, enrolled scores of the patients from the two groups. Although patients
the participants based on inclusion and exclusion criteria, in group A did not receive PONV prophylaxis based on Apfel
obtained written informed consent, and was not blinded to scores, all received the prophylaxis; Apfel scoring was performed
the patient’s allocated group. Observer 2 was the specially to see if the risk for PONV was comparable between the two
instructed nurse or anesthesiology resident who was blinded groups. The types of surgeries (including the laparoscopic
to the group allocation and assessed the number of episodes surgeries) undergone by the patients of both the groups were
of nausea and vomiting in the post‑anesthetic care unit for analyzed and found to be comparable between the two groups.
24 h after surgery. The comparison was performed because the Apfel scoring
system does not take into account the type of surgery as a risk
The primary outcome measure was the incidence of PONV. factor for identifying patients at high risk for PONV.
Vomiting or retching, as reported by the patient or observed
by the nurse, was considered as an emetic episode. This was Table 3 gives the Apfel scores of patients who had PONV.
assessed in the post‑operative period for the first 24 hours. In group B, patients who were stratified to have a low risk
The secondary outcome measures were the cost for prophylaxis for PONV (and hence did not receive prophylaxis) did not
and treatment of PONV. This was calculated by data have PONV.
from the actual cost of ondansetron, metoclopramide, and
dexamethasone when used or there was a potential use for The incidence of PONV during the first 24 h is given in
prophylaxis. Table 4. There was no significant difference in the incidence
of PONV because of implementation of the Apfel scoring
Sample size was calculated using the formula for comparison of system in group B when compared with the incidence of
two proportions, n = (Zα/2 + Zb) 2 * (p1(1‑p1)+p2 (1‑p2))/ PONV in group A. The incidence of PONV does not
(p1‑p2)2, where, n = size of the group, p1 = 0.3 (assuming 30% increase after application of the Apfel scoring system. The
incidence in group A), p2 = 0.4 (incidence of 40% in group B), opioid consumption was compared between the two groups
p1‑p2 = clinically meaningful difference in proportions of the
outcome, β = power of study, Zα/2 = two‑tailed significance ANALYSED FOR
level (1.96 for α at 5% significance), and Zb = 0.84 for ELIGIBILITY (n = 75)
80% power of study. Sample size was estimated based on Excluded (n = 5)
the comparison of incidence of PONV among group A and Surgery cancelled (n = 3)
Declined to participate (n = 2)
group B. Assuming 30% incidence of PONV in group A
and considering an increase in incidence of PONV by 10% in RANDOMIZED (n = 70)
group B because of curtailed PONV prophylaxis to low risk
patients in group B, as significant, the sample size required was
35 in each group with 80% power and 5% level of significance.
GROUP A GROUP B
The incidence was based on the audit of PONV incidence ALLOCATED n = 35 ALLOCATED n = 35
in the institution, which matched with the incidence quoted
in the literature.[3]
ANALYSIS ANALYSIS
n = 35 n = 35
Data were analyzed using SPSS version 16 for Windows
in consultation with the department of medical statistics.
Numerical and categorical data were analyzed using the FOLLOW UP FOLLOW UP
n = 35
Student t‑test, Chi‑square test, or Fisher exact test as n = 35
appropriate. Patient characteristics (age, body weight, body Figure 1: CONSORT flow chart of the study
Table 1: Patient characteristics receive the prophylaxis for PONV from group B as they
Group A Group B P belonged to low risk group based on the Apfel scoring system,
Age (years) 35.9 (12.2) 40.1 (11.7) 0.153 there was no significant increase in the incidence of PONV in
Height (centimeters) 166.8 (8.0) 165.8 (8.6) 0.627 group B when compared to the incidence in group A.
Weight (kilograms) 64.8 (12.1) 63.8 (12.2) 0.724
Body Mass Index (kg/m2) 23.2 (3.6) 23.1 (3.1) 0.850 Since the number of episodes of PONV in the first 24 h was
Gender (Male/Female) 17/20 18/15 0.473 comparable the cost involved in treatment of PONV (Rs 5 per
Data are mean (standard deviation) for age, height, weight, and body mass
index; Student t‑test used. Data are absolute numbers for gender distribution;
ampoule of metoclopramide) was also comparable between
Chi‑square test used the two groups.